Diabetes Drug Discovery
3 - 4 November 2010
Boston, MA, US
This event will provide in-depth presentations about the challenges of developing new diabetes therapies and will focus on examining how cardio-benefit is driving choice of diabetes drug targets. Diabetes therapies developed for non-glucose endpoints will also be explored
Organiser: Cambridge Healthtech Institute